{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:57:05Z","timestamp":1782514625942,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.lfs.2020.117535","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T01:16:36Z","timestamp":1583543796000},"page":"117535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt\/GSK-3\u03b2 and Wnt\/\u03b2-catenin signaling pathways"],"prefix":"10.1016","volume":"249","author":[{"given":"Mina Y.","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther T.","family":"Menze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane G.","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"El-Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117535_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/7854_2010_56","article-title":"Treatment implications of the schizophrenia prodrome","volume":"4","author":"Kaur","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.lfs.2020.117535_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1017\/S0033291704213848","article-title":"Meta-analysis examining the effects of social skills training on schizophrenia","volume":"34","author":"Mueser","year":"2004","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2020.117535_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopsych.2015.07.025","article-title":"A review of oxytocin\u2019s effects on the positive, negative and cognitive domains of schizophrenia","volume":"79","author":"Feifel","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.lfs.2020.117535_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends in Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2020.117535_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0030","doi-asserted-by":"crossref","unstructured":"Higley MJ and Picciotto MR (2014). Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr. Opin. Neurobiol., 0: 88\u201395. doi: https:\/\/doi.org\/10.1016\/j.conb.2014.06.004.","DOI":"10.1016\/j.conb.2014.06.004"},{"issue":"3","key":"10.1016\/j.lfs.2020.117535_bb0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0019-5545.146516","article-title":"Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics","volume":"56","author":"Reyazuddin","year":"2014","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.lfs.2020.117535_bb0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptotic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0055","doi-asserted-by":"crossref","first-page":"ES60","DOI":"10.1017\/S0007114508965776","article-title":"Flavonoids: modulators of brain function?","volume":"99","author":"Spencer","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.lfs.2020.117535_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S0029665108007088","article-title":"Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance","volume":"67","author":"Spencer","year":"2008","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2020.117535_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.foodchem.2006.11.054","article-title":"Citrus flavonoids: molecular structure biological activity and nutritional properties: a review","volume":"104","author":"Tripoli","year":"2007","journal-title":"Food Chem."},{"issue":"10","key":"10.1016\/j.lfs.2020.117535_bb0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2020.117535_bb0075","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.neuint.2011.08.022","article-title":"Neuroprotective effect of naringin, a dietary flavonoid against 3-Nitropropionic acid-induced neuronal apoptosis","volume":"59","author":"Gopinath","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2020.117535_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2015.06.036","article-title":"Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-\u03baB and P53 signaling pathways","volume":"239","author":"Chtourou","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1089\/jmf.2009.1251","article-title":"Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats","volume":"13","author":"Kumar","year":"2010","journal-title":"J. Med. Food"},{"key":"10.1016\/j.lfs.2020.117535_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yebeh.2014.09.058","article-title":"Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of neuroprotection","volume":"41","author":"Golechha","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2020.117535_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.lfs.2020.117535_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2013.05.059","article-title":"Effect of maternal deprivation on acetylcholinesterase activity and behavioral changes on the ketamine-induced animal model of schizophrenia","volume":"248","author":"Zugno","year":"2013","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2020.117535_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","article-title":"Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms","volume":"165","author":"Vasconcelos","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.lfs.2020.117535_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2014.11.002","article-title":"Naringin ameliorates memory deficits in experimental paradigm of Alzheimer\u2019s disease by attenuating mitochondrial dysfunction","volume":"127","author":"Sachdeva","year":"2014","journal-title":"Pharmacol Biochem Be."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/13880209.2015.1070879","article-title":"Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats","volume":"54","author":"Kwatra","year":"2016","journal-title":"Pharm. Biol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2020.117535_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2006.09.010","article-title":"Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes","volume":"552","author":"Bishnoi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2015.09.019","article-title":"Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats","volume":"607","author":"Buuse","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2020.117535_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s002130051015","article-title":"Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis","volume":"144","author":"Becker","year":"1999","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2020.117535_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022059","article-title":"Environmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the rat","volume":"6","author":"Avital","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117535_bb0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2007.06.058","article-title":"Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test","volume":"572","author":"Ishiyama","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2007.08.012","article-title":"Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats","volume":"186","author":"Enomoto","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.lfs.2020.117535_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0091-3057(94)90066-3","article-title":"Social interactions in rats: behavioral and neurochemical alterations in DSP-4-treated rats","volume":"49","author":"Zagrodzka","year":"1994","journal-title":"Pharmacol Biochem Be."},{"key":"10.1016\/j.lfs.2020.117535_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase invitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2020.117535_bb0160","series-title":"Lab Clin. Med","author":"Beutler","year":"1963"},{"key":"10.1016\/j.lfs.2020.117535_bb0165","first-page":"37","volume":"90","author":"Satoh","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2020.117535_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1354\/vp.42-4-405","article-title":"Technical aspects of immunohistochemistry","volume":"42","author":"Ramos-Vara","year":"2005","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.lfs.2020.117535_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin\u2013phenol reagents","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2020.117535_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1751-7893.2011.00286.x","article-title":"Prodromal psychosis screening in adolescent psychiatry clinics","volume":"6","author":"Loewy","year":"2012","journal-title":"Early Interv. Psychiatry."},{"issue":"1","key":"10.1016\/j.lfs.2020.117535_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/sw\/53.1.77","article-title":"Race and hospital diagnoses of schizophrenia and mood disorders","volume":"53","author":"Barnes","year":"2008","journal-title":"Soc. Work"},{"key":"10.1016\/j.lfs.2020.117535_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.059","article-title":"Neural circuit dysfunction in schizophrenia: insights from animal models","volume":"321","author":"Sigurdsson","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2020.117535_bb0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.nicl.2014.10.005","article-title":"GABA and glutamate in schizophrenia: a 7 T 1H-MRS study","volume":"6","author":"Marsman","year":"2014","journal-title":"NeuroImage. Clinical"},{"key":"10.1016\/j.lfs.2020.117535_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnmol.2019.00185","article-title":"NMDAR hypofunction animal models of schizophrenia","volume":"12","author":"Lee","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"22","key":"10.1016\/j.lfs.2020.117535_bb0215","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1523\/JNEUROSCI.2700-12.2013","article-title":"Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2","volume":"33","author":"Ouchi","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2020.117535_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125314557797","article-title":"Drug models of schizophrenia","volume":"5","author":"Steeds","year":"2015","journal-title":"Ther Adv Psychopharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2020.117535_bb0225","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.pnpbp.2009.05.010","article-title":"Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats","volume":"31\u201333","author":"de Oliveira","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2020.117535_bb0230","first-page":"93","article-title":"Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration","volume":"13","author":"Faizi","year":"2014","journal-title":"Iranian Journal of Pharmaceutical Research (IJPR)"},{"key":"10.1016\/j.lfs.2020.117535_bb0235","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","article-title":"Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice","volume":"63","author":"Chatterjee","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2020.117535_bb0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","article-title":"Oxidative stress involvement in schizophrenia pathophysiology: a review","volume":"32","author":"Fendri","year":"2006","journal-title":"L\u2019enc\u00e9phale"},{"issue":"6","key":"10.1016\/j.lfs.2020.117535_bb0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implication","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2020.117535_bb0250","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"The Eur J Neurosci."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0255","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1734-1140(12)70879-4","article-title":"Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia","volume":"64","author":"Rao","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2020.117535_bb0260","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jsfa.3959","article-title":"Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study","volume":"90","author":"Cavia-Saiz","year":"2010","journal-title":"J. Sci. Food Agric."},{"issue":"24","key":"10.1016\/j.lfs.2020.117535_bb0265","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/S0024-3205(01)01363-7","article-title":"Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits","volume":"69","author":"Jeon","year":"2001","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2020.117535_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2014.02.022","article-title":"Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection","volume":"277","author":"Sahu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117535_bb0275","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1038\/sj.onc.1206039","article-title":"Chemotherapy: targeting the mitochondrial cell death pathway","volume":"21","author":"Debatin","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.117535_bb0280","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1101\/lm.1067808","article-title":"Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex","volume":"15","author":"Sui","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.lfs.2020.117535_bb0285","first-page":"1","article-title":"Apigenin attenuates atherogenesis through inducing macrophage apoptosis via inhibition of AKT Ser473 phosphorylation and downregulation of plasminogen activator Inhibitor-2","author":"Zeng","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.lfs.2020.117535_bb0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0924-977X(01)00131-6","article-title":"GSK-3 and the neurodevelopmental hypothesis of schizophrenia","volume":"12","author":"Kozlovsky","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2020.117535_bb0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2009.04.003","article-title":"GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9","volume":"35","author":"Dewachter","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nlm.2010.08.011","article-title":"Sevoflurane impairs memory consolidation in rats, possibly through inhibiting phosphorylation of glycogen synthase kinase-3beta in the hippocampus","volume":"94","author":"Liu","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"issue":"5","key":"10.1016\/j.lfs.2020.117535_bb0305","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1570159X113119990037","article-title":"Neurodevelopment in schizophrenia: the role of the Wnt pathways","volume":"11","author":"Panaccione","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2020.117535_bb0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn2755","article-title":"Emerging roles of Wnts in the adult nervous system","volume":"11","author":"Inestrosa","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2020.117535_bb0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pneurobio.2008.08.001","article-title":"Wnt signaling in neuroprotection and stem cell differentiation","volume":"86","author":"Toledo","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.117535_bb0320","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(90)90385-R","article-title":"The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain","volume":"21\u201362","author":"McMahon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.117535_bb0325","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/npp.2013.128","article-title":"GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine","volume":"38","author":"Liu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2020.117535_bb0330","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1358\/dnp.2007.20.7.1149632","article-title":"The role of glycogen synthase kinase-3beta in schizophrenia","volume":"20","author":"Koros","year":"2007","journal-title":"Drug News Perspect."},{"issue":"4","key":"10.1016\/j.lfs.2020.117535_bb0335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2015.10.152","article-title":"Involvement of periostin-sclerostin-Wnt\/\u03b2-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin","volume":"468","author":"Lv","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520302836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520302836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T13:33:40Z","timestamp":1735392820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520302836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":67,"alternative-id":["S0024320520302836"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117535","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt\/GSK-3\u03b2 and Wnt\/\u03b2-catenin signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117535"}}